NCT03188887View on ClinicalTrials.gov

Treatment of IgA Nephropathy According to Renal Lesions

PHASE3CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

February 20, 2018

Primary Completion Date

January 12, 2024

Study Completion Date

January 12, 2024

Conditions
IgA Nephropathy
Interventions
DRUG

corticotherapy

3 IV pulses steroids followed by oral steroids for 4 months

DRUG

Renin Angiotensin system (RAS) blockade or Inhibitors of sodium glucose transporter 2 (SGLT2i)

treatment with Renin angiotensin system (RAS) blockade or SGLT2i

Trial Locations (1)

75015

Hôpital Necker Enfants-malades, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT03188887 - Treatment of IgA Nephropathy According to Renal Lesions | Biotech Hunter | Biotech Hunter